Table 3.
Univariate Cox regression analysis for endpoint events
| HR | 95% CI | P-value | |
|---|---|---|---|
| Age | 1.024 | 1.008–1.040 | 0.004 |
| Sex | 0.960 | 0.638–1.447 | 0.847 |
| BMI | 1.009 | 0.936–1.087 | 0.817 |
| LVEF | 0.973 | 0.957–0.988 | 0.001 |
| Hypertension | 1.417 | 0.932–2.155 | 0.103 |
| Diabetes | 1.776 | 1.128–2.799 | 0.013 |
| Hyperlipidaemia | 1.065 | 0.592–1.916 | 0.834 |
| Smoking | 1.015 | 0.670–1.537 | 0.944 |
| Atrial fibrillation | 1.726 | 1.006–2.960 | 0.048 |
| STEMI | 1.063 | 0.692–1.634 | 0.780 |
| Coronary stenosis | 1.388 | 0.913–2.110 | 0.126 |
| cTnT | 1.036 | 0.974–1.103 | 0.263 |
| Creatine kinase-MB | 1.003 | 1.000–1.006 | 0.024 |
| NT-proBNP | 1.000 | 1.000-1000 | 0.003 |
| TC | 0.905 | 0.736–1.112 | 0.341 |
| LDL-C | 0.924 | 0.725–1.179 | 0.526 |
| HDL-C | 1.039 | 0.556–1.938 | 0.905 |
| TG | 1.131 | 0.956–1.337 | 0.152 |
| CRP | 1.052 | 0.859–1.288 | 0.621 |
| SHR tertiles | |||
| SHR1 | Reference | Reference | |
| SHR2 | 1.133 | 0.628–2.047 | 0.677 |
| SHR3 | 2.659 | 1.604–4.407 | < 0.001 |
BMI body mass index, LVEF left ventricular ejection fraction, STEMI ST-segment elevation myocardial infarction, cTnT cardiac troponin, NT-proBNP N-terminal pro-brain natriuretic peptide, TC total cholesterol, HDL-C high density lipoprotein, LDL-C low-density lipoprotein, TG triglyceride, CRP C reactive protein, SHR stress hyperglycemia ratio, HR hazard ratio, CI confidence interval